Ambu A/S (AMBBY)
Ambu A/S operates in the Medical - Devices industry of the Healthcare sector, headquartered in Ballerup, CR, DK. The stock last traded at $11.61, up 0.35% on the session, giving a market capitalisation of $3.09B. On trailing twelve-month figures it carries a trailing P/E of 41.57, a net margin of 7.8%. Its beta of 1.39 implies it has historically moved more than the broad market.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Ambu A/S is most often compared with the following Healthcare names: